Cite
APA Citation
Nettekoven, M., Adam, J., Bendels, S., Bissantz, C., Fingerle, J., Grether, U., Grüner, S., Guba, W., Kimbara, A., Ottaviani, G., Püllmann, B., Rogers‐Evans, M., Röver, S., Rothenhäusler, B., Schmitt, S., Schuler, F., Schulz‐Gasch, T., & Ullmer, C. (2016). novel Triazolopyrimidine‐Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases. ChemMedChem, 11(2), 179–189. http://access.bl.uk/ark:/81055/vdc_100028426161.0x00001b